Sage Therapeutics (SAGE) Earnings
|
Expand Research on SAGE
| Next EPS Date | N/A | EPS Growth Rate | +53.5% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.6% | Revenue Growth Rate | +266.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -9.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/25  |
Q225 | -$0.79 | -$0.94 | +$0.15 | $31.66M | $16.75M | N/A |  | | Details | |
| 4/29/25 | Q125 | -$1.01 | -$0.99 | -$0.02 | $14.06M | $14.14M | N/A | | | Details | |
| 2/11/25 | Q424 | -$1.56 | -$1.50 | -$0.06 | $12.81M | $14.08M | N/A | | | Details | |
| 10/29/24 | Q324 | -$1.53 | -$1.54 | +$0.01 | $11.87M | $10.8M | N/A | | | Details | |
| 7/31/24 | Q224 | -$1.70 | -$1.64 | -$0.06 | $8.65M | $8.75M | N/A | | | Details | |
| 4/25/24 | Q124 | -$1.80 | -$1.65 | -$0.15 | $7.9M | $5.11M | N/A | | | Details | |
| 2/14/24 | Q423 | -$0.55 | -$1.28 | +$0.73 | $77.97M | $60.01M | N/A | | | Details | |
| 11/7/23 | Q323 | -$3.37 | -$2.68 | -$0.69 | $2.72M | $4.63M | N/A | | | Details |
